GB202012160D0 - New compositions - Google Patents

New compositions

Info

Publication number
GB202012160D0
GB202012160D0 GBGB2012160.4A GB202012160A GB202012160D0 GB 202012160 D0 GB202012160 D0 GB 202012160D0 GB 202012160 A GB202012160 A GB 202012160A GB 202012160 D0 GB202012160 D0 GB 202012160D0
Authority
GB
United Kingdom
Prior art keywords
new compositions
compositions
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2012160.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vicore Pharma AB
Original Assignee
Vicore Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vicore Pharma AB filed Critical Vicore Pharma AB
Priority to GBGB2012160.4A priority Critical patent/GB202012160D0/en
Publication of GB202012160D0 publication Critical patent/GB202012160D0/en
Priority to PCT/GB2021/052014 priority patent/WO2022029429A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB2012160.4A 2020-08-05 2020-08-05 New compositions Ceased GB202012160D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2012160.4A GB202012160D0 (en) 2020-08-05 2020-08-05 New compositions
PCT/GB2021/052014 WO2022029429A1 (en) 2020-08-05 2021-08-04 New injectable formulations comprising immunomodulator drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2012160.4A GB202012160D0 (en) 2020-08-05 2020-08-05 New compositions

Publications (1)

Publication Number Publication Date
GB202012160D0 true GB202012160D0 (en) 2020-09-16

Family

ID=72425256

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2012160.4A Ceased GB202012160D0 (en) 2020-08-05 2020-08-05 New compositions

Country Status (2)

Country Link
GB (1) GB202012160D0 (en)
WO (1) WO2022029429A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201590883A1 (en) * 2012-11-05 2015-09-30 Селджин Корпорейшн TREATMENT OF CANCER POMALIDOMIDE IN THE SUBJECT WITH RENAL FAILURE
WO2017058754A1 (en) * 2015-09-28 2017-04-06 Celgene Corporation Combination therapy for treatment of hematological cancers and solid tumors
CN105998019A (en) * 2016-06-29 2016-10-12 青岛云天生物技术有限公司 Medicine composition for treating brain glioma and application thereof

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
"Guidance for Industry Container Closure System for Packaging Human Drugs and Biologies", May 1999, FDA, CDER
"ICH Q6A, Note for Guidance Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances (CPMP/ICH/367/96", May 2000, EMEA
"Remington The Science and Practice of Pharmacy", 1995, MACK PRINTING COMPANY
CARLESIMO ET AL., J. AM. ACAD. DERMATOL., vol. 32, 1995, pages 866
COLOMBO ET AL., INT. J. PHARM., vol. 514, 2016, pages 229
DON ET AL., AM. J. TRANSL. RES., vol. 9, 2017, pages 4390
FAZZI ET AL., BIOMEDICIN & PHARMACOTHERAPY, vol. 66, 2012, pages 300
HARAF ET AL., AM. J. THER., vol. 1, 2017
HORTON ET AL., ANN. INTERN. MED., vol. 157, 2012, pages 398
MARTINDALE: "The Complete Drug Reference"
TABATA ET AL., J. IMMUNOL., vol. 179, 2007, pages 708
ZHANGYANG, JOURNAL OF XI'AN JIATONG UNIVERSITY (MEDICAL SCIENCES), vol. 33, 2012, pages 622
ZHAO ET AL., CLIN. EXP. IMMUNOL., vol. 157, 2000, pages 310

Also Published As

Publication number Publication date
WO2022029429A1 (en) 2022-02-10

Similar Documents

Publication Publication Date Title
GB202005593D0 (en) New composition
GB202013432D0 (en) Compositions
GB202006079D0 (en) New composition
GB202006074D0 (en) New composition
GB202015836D0 (en) Compositions
GB202006081D0 (en) New composition
GB202105461D0 (en) Compositions
GB202102704D0 (en) Compositions
GB202019952D0 (en) Novel compositions
GB202017863D0 (en) Novel compositions
GB202005586D0 (en) New composition
GB202114311D0 (en) New compositions
GB202012160D0 (en) New compositions
GB202012152D0 (en) New compositions
ZA202210764B (en) Compositions
GB202208611D0 (en) Compositions
GB202118081D0 (en) Compositions
GB202117074D0 (en) Compositions
GB202116861D0 (en) Compositions
GB202116388D0 (en) Compositions
GB202116386D0 (en) Compositions
GB202116387D0 (en) Compositions
GB202115617D0 (en) Compositions
GB202114053D0 (en) Compositions
GB202111897D0 (en) Compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)